Percutaneous coronary intervention in patients aged 80 years old and above: a systematic review and meta-analysis

Norman H Lin1, Jamie S-Y Ho2, Andie Hartanto Djohan1

  • 1Department of Cardiology, National University Heart Centre, Singapore.

Asiaintervention
|December 9, 2022
PubMed

Insights

Elderly patients (80+) undergoing percutaneous coronary intervention (PCI) face high mortality risks. This study found significant rates of death and major adverse cardiac events (MACE) within 3 years post-PCI, highlighting the need for further research.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Ischaemic heart disease is a leading global cause of death.
  • Elderly patients (80+ years) undergoing percutaneous coronary intervention (PCI) have elevated risks of mortality and complications due to age, frailty, and comorbidities.

Purpose of the Study:

  • To evaluate the overall outcomes for patients aged 80 years and above who undergo PCI.
  • To analyze mortality and major adverse cardiac events (MACE) in this high-risk demographic.

Main Methods:

  • A systematic review and meta-analysis of studies involving patients aged 80+ undergoing PCI for any indication.
  • Databases searched include PUBMED, EMBASE, SCOPUS, and CENTRAL.
  • Pooled outcomes included all-cause death, cardiac death, in-hospital death, stroke/transient ischaemic attack (TIA), myocardial infarction (MI), congestive cardiac failure (CCF), and MACE.

Main Results:

  • The study analyzed data from 2,566,004 patients.
  • Pooled cumulative incidences: 19.22% all-cause death, 7.78% cardiac death, 7.16% in-hospital death, 1.54% stroke/TIA, 3.58% MI, 4.74% CCF, and 17.51% MACE.
  • Three-year mortality reached 33.27%. ST-elevation MI patients showed higher in-hospital death and 1-year mortality rates compared to non-ST-elevation MI patients.

Conclusions:

  • Senior patients aged 80 and above experience high mortality rates at 1 and 3 years post-PCI, irrespective of the indication.
  • These findings underscore the critical need for further investigation into the management and outcomes of this vulnerable patient group.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
19
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
15
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
21